Christopher Rountree

Christopher Rountree, MBA, has a strong background in healthcare sales and business development. Christopher is currently the National Director of 340B Accounts at BioPlus Specialty Pharmacy, a role they assumed in April 2023. Prior to this, they served as the Regional Sales Director at the same company from March 2021 to March 2023.

Before joining BioPlus, Christopher worked at McKesson from October 2019 to November 2020, where they focused on business development in infusion management. From November 2017 to September 2019, they were the Health Systems Sales Director at Express Scripts' Accredo Specialty Pharmacy division, where they led sales efforts to grow the pharmacy services in high-priority hospitals and health systems.

Christopher's career in healthcare sales began at Pfizer, where they held various positions from 2006 to 2014. Christopher started as a Healthcare Sales Representative and later became a Hospital Account Manager, managing regional operations and implementing strategic initiatives. Prior to that, they worked as an Assurance Associate at PricewaterhouseCoopers from 2004 to 2006.

Throughout their career, Christopher has demonstrated expertise in building relationships, generating sales growth, and improving patient care through their strong pharmaceutical industry knowledge.

Christopher Rountree, MBA obtained a Bachelor's degree in Accounting from Saint Joseph's University from 2001 to 2005. More recently, they completed their Master of Business & Healthcare Administration in Health/Health Care Administration/Management at Wilmington University, spanning from 2018 to 2021.